The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Carboplatin dosing in the treatment of epithelial ovarian cancer (EOC): A Gynecologic Oncology Group (GOG) study.
Roisin Eilish O'Cearbhaill
No relevant relationships to disclose
Austin Miller
No relevant relationships to disclose
Franco Muggia
No relevant relationships to disclose
Judith A. Smith
No relevant relationships to disclose
Michael A. Bookman
No relevant relationships to disclose
Paul Sabbatini
No relevant relationships to disclose